Litcius/Paper detail

1966MO EV-302: Exploratory analysis of nectin-4 expression and response to 1L enfortumab vedotin (EV) + pembrolizumab (P) in previously untreated locally advanced or metastatic urothelial cancer (la/mUC)

Thomas Powles, Michiel S. van der Heijden, Shilpa Gupta, Begoña P. Valderrama, M.D. Galsky, J. Bedke, Eiji Kikuchi, Jean Hoffman‐Censits, J.P. Maroto Rey, Christof Vulsteke, Gopa Iyer, Umang Swami, Sang Joon Shin, Alejo Rodríguez‐Vida, Michał Woźniak, Blanca Homet Moreno, Jie Lu, Changjun Yu, Leah J. Hogdal, Yohann Loriot

2024Annals of Oncology23 citationsDOIOpen Access PDF

Topics & Concepts

MedicineUrothelial cancerPembrolizumabOncologyInternal medicineCancer researchCancerImmunotherapyBladder cancerBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesUrological Disorders and Treatments